MSN LABORATOTIES PVT LTD

MSN Laboratories Pvt. Ltd. is a Manufacturer.

MSN Laboratories Pvt. Ltd. is a leading Indian pharmaceutical company, recognized as one of the fastest-growing pharmaceutical companies in the country. The company is primarily engaged in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs).

Headquartered in Hyderabad, India, MSN Laboratories operates multiple state-of-the-art manufacturing facilities that comply with global regulatory standards, including those of the US FDA, EU GMP, and others. Their extensive product portfolio covers a wide range of therapeutic areas, aiming to provide high-quality, affordable medicines to patients worldwide. With a strong emphasis on innovation and robust research and development capabilities, MSN Laboratories is committed to developing new molecules and bringing cost-effective healthcare solutions to the global market.

MSN Laboratories Pvt Ltd manufactures and sells a wide range of pharmaceutical products, primarily categorized into Active Pharmaceutical Ingredients (APIs) and Finished Dosage Formulations (FDFs).

Active Pharmaceutical Ingredients (APIs)

MSN is a major global manufacturer of APIs, covering numerous therapeutic segments. Their API portfolio includes products for:

Cardiovascular diseases (e.g., Atorvastatin, Rosuvastatin)

Central Nervous System (CNS) disorders (e.g., Pregabalin, Gabapentin)

Diabetes (e.g., Metformin, Sitagliptin)

Gastrointestinal disorders (e.g., Pantoprazole, Rabeprazole)

Pain and Inflammation (e.g., Ibuprofen, Diclofenac)

Anti-infectives (e.g., Cefixime, Azithromycin)

Antivirals (e.g., Remdesivir related compounds, Favipiravir)

Antifungals

Anticancer (Oncology) drugs

Respiratory disorders

Urology

And many other therapeutic categories.

Finished Dosage Formulations (FDFs)

MSN Laboratories also manufactures and markets a comprehensive range of finished dosage forms across various therapeutic areas. These formulations are available in different dosage forms, including:

Tablets

Capsules

Oral Liquids (Syrups, Suspensions)

Injections (Sterile products)

Topical preparations

Therapeutic categories for FDFs include:

Cardiology

Diabetology

Neurology

Gastroenterology

Pain Management

Anti-infectives

Oncology

Respiratory

Nephrology

And other therapeutic areas.

Key Focus Areas

Oncology: MSN has a significant focus and extensive portfolio in oncology, encompassing both API and formulation development and manufacturing for various cancer treatments.

Injectables: They possess dedicated facilities and expertise in producing a wide array of sterile injectable products.